|
FDMT 4D Molecular Therapeutics Inc 1650648 |
| Balance Sheet |
|
Current Assets
|
$405,364,000.00 |
|
Assets
|
$512,905,000.00 |
|
Current Liabilities
|
$43,404,000.00 |
|
Liabilities
|
$61,069,000.00 |
|
Equity
|
$451,836,000.00 |
|
Shares Out
|
52271648.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-68,125,000.00 |
|
Investing Cash Flow
|
$68,888,000.00 |
| Market Analysis |
Market Cap
|
$526,375,495.36 |
|
Price
|
$9.89 |
|
BVPS
|
8.64 |
|
PB
|
1.17 |
|
EPS
|
-1.01 |
|
PS
|
55.75 |
|
FCF
|
$-68,661,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:29 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:25 |
|
| Apr |
May |
Jun |
| 2026-03-18 |
-2.42 |
|
|
2026-05-07 |
-1.01 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-11 |
-0.98 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-10 |
-1.01 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view FDMT documents filed with the SEC.
FDMT Filings
Clear
